中国全科医学2017，Vol.20Issue(33)：4091-4095,4104,6.DOI:10.3969/j.issn.1007-9572.2017.00.132
2017年ACP《2型糖尿病口服药物治疗临床实践指南》解读
Interpretation of Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus : a Clinical Practice Guideline Update from the American College of Physicians
蒋升1
作者信息
- 1. 830013新疆乌鲁木齐市,新疆医科大学第一附属医院内分泌科
- 折叠
摘要
Abstract
As the incidence of type 2 diabetes has been on the rise,and oral administration of hypoglycemic drugs has been the main means for treating the disease,studying and popularizing the guide to the oral medication for type 2 diabetes is helpful to the prevention and treatment of the disease.This article is about an interpretation of Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus:a Clinical Practice Guideline Update from the American College of Physicians (hereinafter referred to as the guideline) published in 2017.Compared with the guideline of 2012,in the new guideline,the characteristics and types of oral hypoglycemic drugs for type 2 diabetes were further summarized,supplemented by the latest found clinical evidences,and the following recommendations were put forward:first,when oral pharmacologic therapy is needed,clinicians should prefer metformin to improve the fasting blood glucose level;second,when there is a need for adding a second agent to metformin for further improving the blood glucose control,clinicians can select sulfonylureas,thiazolidinediones,SGLT-2 inhibitors or DPP-4 inhibitors.All of these will lead to the improvement of rational choice of oral drugs for adults with type 2 diabetes mellitus.关键词
糖尿病,2型/药物疗法/指南Key words
Diabetes mellitus, type 2/Drug therapy/Guidebooks分类
医药卫生引用本文复制引用
蒋升..2017年ACP《2型糖尿病口服药物治疗临床实践指南》解读[J].中国全科医学,2017,20(33):4091-4095,4104,6.
